JP2020506209A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020506209A5 JP2020506209A5 JP2019543311A JP2019543311A JP2020506209A5 JP 2020506209 A5 JP2020506209 A5 JP 2020506209A5 JP 2019543311 A JP2019543311 A JP 2019543311A JP 2019543311 A JP2019543311 A JP 2019543311A JP 2020506209 A5 JP2020506209 A5 JP 2020506209A5
- Authority
- JP
- Japan
- Prior art keywords
- amisulpride
- medicament according
- motomeko
- agent
- antiemetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022196161A JP7526244B2 (ja) | 2017-02-10 | 2022-12-08 | 術後悪心嘔吐の救援治療 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1702250.0 | 2017-02-10 | ||
| GBGB1702250.0A GB201702250D0 (en) | 2017-02-10 | 2017-02-10 | Method |
| PCT/GB2018/050374 WO2018146490A1 (en) | 2017-02-10 | 2018-02-09 | Rescue treatment of post operative nausea and vomiting |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022196161A Division JP7526244B2 (ja) | 2017-02-10 | 2022-12-08 | 術後悪心嘔吐の救援治療 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2020506209A JP2020506209A (ja) | 2020-02-27 |
| JP2020506209A5 true JP2020506209A5 (https=) | 2022-06-14 |
| JPWO2018146490A5 JPWO2018146490A5 (https=) | 2022-06-14 |
| JP7333269B2 JP7333269B2 (ja) | 2023-08-24 |
Family
ID=58462198
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019543311A Active JP7333269B2 (ja) | 2017-02-10 | 2018-02-09 | 術後悪心嘔吐の救援治療 |
| JP2022196161A Active JP7526244B2 (ja) | 2017-02-10 | 2022-12-08 | 術後悪心嘔吐の救援治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022196161A Active JP7526244B2 (ja) | 2017-02-10 | 2022-12-08 | 術後悪心嘔吐の救援治療 |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US11357753B2 (https=) |
| EP (1) | EP3579831A1 (https=) |
| JP (2) | JP7333269B2 (https=) |
| KR (2) | KR20240001288A (https=) |
| CN (1) | CN110603036A (https=) |
| AU (2) | AU2018218310B2 (https=) |
| BR (1) | BR112019016565A2 (https=) |
| EA (1) | EA201991667A1 (https=) |
| GB (1) | GB201702250D0 (https=) |
| IL (2) | IL268591B2 (https=) |
| MX (1) | MX388736B (https=) |
| NZ (1) | NZ796242A (https=) |
| WO (1) | WO2018146490A1 (https=) |
| ZA (1) | ZA201905212B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201702250D0 (en) * | 2017-02-10 | 2017-03-29 | Acacia Pharma Ltd | Method |
| IT201900013524A1 (it) | 2019-07-31 | 2021-01-31 | Laboratori Baldacci Spa | Nuove formulazioni di amisulpride |
| CN115867271A (zh) * | 2020-07-06 | 2023-03-28 | 阿卡西亚制药有限公司 | 术后恶心和呕吐的疗法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1004020A (en) | 1964-04-24 | 1965-09-08 | Standard Telephones Cables Ltd | Improvements in or relating to the mounting of electrical components |
| FR2415099A1 (fr) | 1978-01-20 | 1979-08-17 | Ile De France | Nouveaux derives de 4-amino-5-alkylsulfonyl ortho-anisamides, leurs procedes de preparation et leur application comme psychotropes |
| GB9305593D0 (en) | 1993-03-18 | 1993-05-05 | Smithkline Beecham Plc | Pharmaceuticals |
| US6169094B1 (en) | 1998-07-14 | 2001-01-02 | Sanofi-Synthelabo | Compositions of (S) (-)-amisulpride |
| DE10163421A1 (de) | 2001-12-21 | 2003-07-31 | Gruenenthal Gmbh | Verwendung von (+)-(1S,2S)-3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)phenol als Antiemetikum |
| TWI355936B (en) | 2003-02-18 | 2012-01-11 | Helsinn Healthcare Sa | Uses of palonosetron hydrochloride |
| DE102005013726A1 (de) | 2005-03-22 | 2006-09-28 | Grünenthal GmbH | Transdermale therapeutische Systeme mit verbesserter Verträglichkeit |
| GB0506800D0 (en) | 2005-04-04 | 2005-05-11 | Merck Sharp & Dohme | New uses |
| WO2007067714A2 (en) | 2005-12-08 | 2007-06-14 | The Mclean Hospital Corporation | Treatment of sequelae of psychiatric disorders |
| CN103211779B (zh) | 2006-01-27 | 2016-03-16 | 阿代尔制药股份有限公司 | 包含弱碱性选择性5-羟色胺5-ht3阻断剂和有机酸的药物递送系统 |
| EP1988883A1 (fr) | 2006-02-17 | 2008-11-12 | Trimaran Limited | Nouvelles compositions pharmaceutiques destinees a optimiser des traitements de substitution et elargir la pharmacopee au traitement global des addictions |
| US7825156B2 (en) | 2007-02-02 | 2010-11-02 | Copharms | Method of treating bipolar depression with a benzamide derivative |
| ES2620672T3 (es) | 2008-01-09 | 2017-06-29 | Charleston Laboratories, Inc. | Comprimidos de doble capa que comprenden oxicodona y prometazina |
| US8138169B2 (en) | 2008-04-11 | 2012-03-20 | Comgenrx, Inc. | Combination therapy for bipolar disorder |
| US20110003005A1 (en) | 2009-07-06 | 2011-01-06 | Gopi Venkatesh | Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions |
| PT2722045T (pt) | 2009-11-18 | 2016-10-18 | Helsinn Healthcare Sa | Composições para o tratamento de náuseas e vómitos mediadas centralmente |
| GB201004020D0 (en) | 2010-03-11 | 2010-04-21 | Acacia Pharma Ltd | New therapeutic use |
| US8691836B2 (en) | 2010-06-18 | 2014-04-08 | Altos Therapeutics, LLC | D2 antagonists, methods of synthesis and methods of use |
| WO2015054429A1 (en) | 2013-10-08 | 2015-04-16 | Innopharma, Inc | Aprepitant oral liquid formulations |
| GB201506116D0 (en) | 2015-04-10 | 2015-05-27 | Acacia Pharma Ltd | Kit and combination therapy for nausea and vomiting |
| GB201618425D0 (en) | 2016-11-01 | 2016-12-14 | Acacia Pharma Ltd | method |
| GB201702250D0 (en) | 2017-02-10 | 2017-03-29 | Acacia Pharma Ltd | Method |
-
2017
- 2017-02-10 GB GBGB1702250.0A patent/GB201702250D0/en not_active Ceased
-
2018
- 2018-02-09 AU AU2018218310A patent/AU2018218310B2/en active Active
- 2018-02-09 JP JP2019543311A patent/JP7333269B2/ja active Active
- 2018-02-09 EP EP18705483.8A patent/EP3579831A1/en active Pending
- 2018-02-09 KR KR1020237044292A patent/KR20240001288A/ko active Pending
- 2018-02-09 CN CN201880011444.1A patent/CN110603036A/zh active Pending
- 2018-02-09 KR KR1020197023506A patent/KR20190111993A/ko not_active Ceased
- 2018-02-09 IL IL268591A patent/IL268591B2/en unknown
- 2018-02-09 IL IL298486A patent/IL298486B2/en unknown
- 2018-02-09 EA EA201991667A patent/EA201991667A1/ru unknown
- 2018-02-09 MX MX2019009507A patent/MX388736B/es unknown
- 2018-02-09 BR BR112019016565-7A patent/BR112019016565A2/pt not_active Application Discontinuation
- 2018-02-09 NZ NZ796242A patent/NZ796242A/en unknown
- 2018-02-09 WO PCT/GB2018/050374 patent/WO2018146490A1/en not_active Ceased
- 2018-02-09 US US16/485,008 patent/US11357753B2/en active Active
-
2019
- 2019-08-07 ZA ZA2019/05212A patent/ZA201905212B/en unknown
-
2022
- 2022-05-17 US US17/746,032 patent/US12005042B2/en active Active
- 2022-12-08 JP JP2022196161A patent/JP7526244B2/ja active Active
-
2024
- 2024-05-02 US US18/653,318 patent/US12329740B2/en active Active
- 2024-05-13 AU AU2024203155A patent/AU2024203155B2/en active Active
-
2025
- 2025-05-19 US US19/211,545 patent/US20250367211A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107872975A (zh) | 用于治疗恶心和呕吐的氨磺必利和其它止吐药的组合 | |
| Pergolizzi Jr et al. | Perspectives on transdermal scopolamine for the treatment of postoperative nausea and vomiting | |
| JP2009525343A5 (https=) | ||
| JP2020506209A5 (https=) | ||
| NZ749192A (en) | Ar+ breast cancer treatment methods | |
| JP2012131811A5 (https=) | ||
| NZ792518A (en) | Formulations for administration of eflornithine | |
| JP2017513809A5 (https=) | ||
| JP2020523356A5 (https=) | ||
| Yoo et al. | Aprepitant in combination with palonosetron for the prevention of postoperative nausea and vomiting in female patients using intravenous patient-controlled analgesia | |
| JP2019508476A5 (https=) | ||
| JP2023027213A (ja) | 術後悪心嘔吐の救援治療 | |
| Markman | Progress in preventing chemotherapy-induced nausea and vomiting | |
| Girish et al. | Aprepitant: a substance P antagonist for chemotherapy induced nausea and vomiting | |
| JP2020516663A5 (https=) | ||
| Martins et al. | Analgesic efficacy of ketorolac associated with a tramadol/acetaminophen combination after third molar surgery-a randomized, triple-blind clinical trial | |
| JP2016505050A5 (https=) | ||
| NZ751972A (en) | Treatment of prurigo nodularis | |
| NZ756051B2 (en) | Rescue treatment of post operative nausea and vomiting | |
| Koch | Severe quetiapine withdrawal syndrome with nausea and vomiting in a 65-year-old patient with psychotic depression | |
| MX2018005876A (es) | Regimen de dosificacion de plasminogeno para la cicatrizacion de heridas. | |
| Jacob et al. | Prospective Randomized case control study of Oral Aprepitant for the prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) | |
| JPWO2022008901A5 (https=) | ||
| Sharma et al. | Managing Hyperemesis in the Era of Concurrent and Sequential Chemo-radiation | |
| Cardenas-Mori et al. | Corticosteroids for common palliative care symptoms# 395 |